Pacific Biosciences Of California (PACB) Return on Sales (2010 - 2026)

Pacific Biosciences Of California's Return on Sales history runs 17 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales rose 11.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (up 4.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Pacific Biosciences Of California, up from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2024 to a low of 0.11% in Q1 2025.
• Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.02% in 2024.
• The sharpest annual moves came in 2025 and 2026: Return on Sales declined 9 bps in 2025, then climbed 11 bps in 2026.
• A 5-year view of Return on Sales shows it stood at 0.03% in 2022, then jumped by 54 bps to 0.01% in 2023, then surged by 104 bps to 0.0% in 2024, then sank by 1596 bps to 0.01% in 2025, then jumped by 75 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.